Evaluation and treatment of male and female pattern hair loss.
Olsen
Elise A
EA
Duke University Medical Center, Durham, North Carolina 27710, USA.
Messenger
Andrew G
AG
Shapiro
Jerry
J
Bergfeld
Wilma F
WF
Hordinsky
Maria K
MK
Roberts
Janet L
JL
Stough
Dow
D
Washenik
Ken
K
Whiting
David A
DA
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000502:physiology; D058891:5-alpha Reductase Inhibitors; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000505:Alopecia / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D000726:Androgen Antagonists / Q000627:therapeutic use; D000075202:Contraindications; D003357:Cosmetic Techniques; D017373:Cyproterone Acetate / Q000627:therapeutic use; D003937:Diagnosis, Differential; D013196:Dihydrotestosterone / Q000378:metabolism; D005260:Female; D018120:Finasteride / Q000627:therapeutic use; D012739:Gonadal Steroid Hormones / Q000097:blood; D006197:Hair / Q000473:pathology; D018859:Hair Follicle / Q000502:physiology / Q000637:transplantation; D006801:Humans; D007037:Hypothyroidism / Q000175:diagnosis; D000090463:Iron Deficiencies; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000502:physiology; D008297:Male; D008875:Middle Aged; D008914:Minoxidil / Q000008:administration & dosage / Q000627:therapeutic use; D011944:Receptors, Androgen / Q000502:physiology; D012727:Sex Characteristics; D013148:Spironolactone / Q000627:therapeutic use
D058891:5-alpha Reductase Inhibitors; D000726:Androgen Antagonists; D012739:Gonadal Steroid Hormones; D007527:Isoenzymes; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D013148:Spironolactone; D017373:Cyproterone Acetate; D018120:Finasteride; D008914:Minoxidil; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase